S. Sequero-López

Overcome after Special Use of Bridging Therapy in Refractory DLBCL Subsequently Treated with CAR-T Cell

C. Prieto, S. Sequero-López, 2021 .

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

M. Pirmohamed, A. Cambon-Thomsen, Yitian Zhou, 2023, The Lancet.